Moderna (NASDAQ: MRNA)
Moderna Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Moderna Company Info
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA).
News & Analysis
2 Beaten-Down Stocks to Buy and Hold for a Decade
These biotechs should benefit from their innovative ways.
Biotech vs. Pharma: What's the Difference?
Is it Time to Dump Your Shares of Moderna?
Moderna is working with advanced technology to help transform the way medicines are created, but is that enough reason to stick around?
Top Commercial Real Estate Stocks
Commercial real estate stocks offer opportunities to get involved with some of the most interesting businesses in the world.
Investing in Vaccine Stocks
Learn about the companies that are manufacturing vaccines and what you should know before investing in vaccine stocks.
The 3 Things That Matter for Moderna Now
The company is still trying to prove that it isn't just a pandemic play.
Down 74% Over the Past Year, Is Moderna Stock a Buy?
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash
Valuation
Podcast Episodes
Microsoft's Gaming Ambitions and COVID-19 Stocks
Microsoft CEO Satya Nadella talked about his company's doubling down on gaming, which should give gamers and investors pause.
What Gives Moderna's Coronavirus Vaccine an Edge?
Moderna has got some promising news on the coronavirus vaccine front.
Why Moderna Stock Is Up
Moderna shares got a boost as the company continued its COVID-19 vaccine trials.
Why Moderna Stock Just Went Up
Encouraging news coming out of the biotech regarding its coronavirus vaccine candidate caused its stock to pop.
Earnings Transcripts
Moderna (MRNA) Q4 2024 Earnings Call Transcript
MRNA earnings call for the period ending December 31, 2024.
Moderna (MRNA) Q3 2024 Earnings Call Transcript
MRNA earnings call for the period ending September 30, 2024.
Moderna (MRNA) Q2 2024 Earnings Call Transcript
MRNA earnings call for the period ending June 30, 2024.
Moderna (MRNA) Q1 2024 Earnings Call Transcript
MRNA earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.